1858 Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$483K Sell
5,759
-1,082
-16% -$89.1K 0.34% 55
2025
Q2
$542K Sell
6,841
-1,651
-19% -$131K 0.4% 56
2025
Q1
$762K Sell
8,492
-677
-7% -$63.2K 0.65% 48
2024
Q4
$912K Sell
9,169
-8,743
-49% -$901K 0.72% 40
2024
Q3
$2.03M Buy
17,912
+76
+0.4% +$9.03K 1.67% 17
2024
Q2
$2.21M Sell
17,836
-2,744
-13% -$353K 1.83% 15
2024
Q1
$2.24M Hold
20,580
2.13% 12
2023
Q4
$2.24M Buy
+20,580
New +$2.14M 2.13% 12

Other funds holding MRK

1858 Wealth Management's MRK Position: Q3 2025 in Review

1858 Wealth Management reduced its Merck (MRK) stake by 16% in Q3 2025, selling an estimated $89.1K and leaving 5,759 shares worth $483K. The position accounts for 0.34% of the portfolio, ranked #55.

1858 Wealth Management first reported a position in MRK in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.24M in Q1 2024. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • 1858 Wealth Management held 5,759 shares of Merck worth $483K as of Q3 2025.
  • 1858 Wealth Management sold 1,082 Merck shares in Q3 2025, an estimated $89.1K.
  • Merck made up 0.34% of 1858 Wealth Management's portfolio in Q3 2025, its #55 holding.
  • 1858 Wealth Management first reported a position in Merck in Q4 2023 and has held it in 8 quarters since.
  • 1858 Wealth Management's Merck position peaked at $2.24M in Q1 2024.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on 1858 Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.